Very recently, the World Health Organization, which is essentially the United Nations’ agency for coordinating international health-related efforts, has launched The Global Online Consultation on Research Priority Setting for Healthy Aging. A corresponding survey is available on the WHO website and can be filled until September 30. As WHO is the main source of policy…

Since population aging was first brought to the attention of the United Nations by the Government of Malta in 1968, our society began its journey to find adequate measures of adaptation to the growing share of older people and its impact on different aspects of social life. However, the Vienna International Plan of Action on…

We are delighted to hear that the SENS Research Foundation and the Forever Healthy Foundation have joined forces to host an exciting conference about rejuvenation biotechnology on March 15-17, 2018 at the Umspannwerk Alexanderplatz in Berlin, Germany. A new show open to the wider audience The particularly good news is that this conference will be open…

In the last year or so, we have seen remarkable progress with a number of interventions that target the aging processes to prevent and treat age-related diseases. Senescent cell clearance has enjoyed lots of media attention and is entering human clinical trials later this year with Unity Biotechnology. We have LysoCLEAR from Ichor Therapeutics moving towards…

There is a persistent view that life extension advocacy is something that does not require any investments and can be done in your spare time. Fundraising for overheads is like an elephant in the room: it is hard not to notice it is there, but people try to avoid talking about it. The truth is,…

Life extensionism is a global movement with long-term traditions. The idea, that aging is similar to a disease and should be treated as such, was first suggested in early 1900s by Elie Metchnikoff, the Nobel Laureate in Physiology/Medicine of 1908 for the discovery of phagocytosis, a vice director of the Pasteur Institute (Paris). Since then,…

LEAF Director Elena Milova recently attended the International Longevity and Cryopreservation Summit in Madrid and gave a talk about effective advocacy and how we can engage better with the public as advocates for rejuvenation biotechnology. Her talk touches upon effective message delivery as well as the basic principles of teaching, known as the didactic principles….

One of the most frequent questions we get from the general public is, when will rejuvenation therapies arrive? Whilst young people might be able to wait for a few more decades, those in middle age are much more concerned. According to statistics, new drug/therapy development takes 17 years on average, but the countdown only begins at the…

We have prepared this handy cheat sheet to help advocates better prepare the audience to understand and think about rejuvenation biotechnology. 

Appropriate funding is crucial for scientific progress; this is especially true in the case of basic science. Fundamental studies do not deliver a final product or potential revenue in a short-term, so the most wealthy stakeholders in R&D – a business – are unlikely to invest their money in them.    Studies exploring the main…

© 2017 - LIFE EXTENSION ADVOCACY FOUNDATION
Privacy Policy / Terms Of Use

       Powered by MMD